Search results
Results from the WOW.Com Content Network
Theranos Inc. (/ ˈ θ ɛr. ə n. oʊ s /) was an American privately held corporation [5] that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $9 billion valuation at its peak in 2013 and 2014.
They’re all over television: advertisements for companies saying they’ll “negotiate” with the IRS on behalf of taxpayers to try to get tax debt reduced or eliminated.
Reports on the purported scam are an Internet hoax, first spread on social media sites in 2017. [1] While the phone calls received by people are real, the calls are not related to scam activity. [1] According to some news reports on the hoax, victims of the purported fraud receive telephone calls from an unknown person who asks, "Can you hear me?"
Critical Reviews in Biotechnology is an academic journal that publishes comprehensive review articles that organize, evaluate and present the current status of issues in biotechnology. Core areas [ edit ]
Bipartisan bills introduced in Congress Thursday would effectively ban a Chinese genomics firm from doing business in America. Intel officials have warned China is grabbing U.S. genetic info.
Since around 2008, GcMAF has been promoted as a cure for cancer, [5] HIV, [6] autism [7] and other conditions. [8]Three out of four of the original studies authored by Yamamoto (published between 2007 and 2009) were retracted by the scientific journals in which they were published in 2014, officially due to irregularities in the way ethical approval was granted.
Scareware is part of a class of malicious software that includes rogue security software, ransomware and other scam software that tricks users into believing their computer is infected with a virus, then suggests that they download and pay for fake antivirus software to remove it. [2]
On June 29, 2017, Muddy Waters opened research into Prothena Corp PLC, a biotech company whose leading product the shortseller claimed was commercially unviable. [18] In August 2019, Muddy Waters announced that it was short Burford Capital, [19] [20] citing issues, as Muddy Waters saw it, with Burford's fair value accounting practices. [21]